Biotage AB Financials
Based on the measurements of operating efficiency obtained from Biotage AB's historical financial statements, Biotage AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in June.
With this module, you can analyze Biotage financials for your investing period. You should be able to track the changes in Biotage AB individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Biotage |
Understanding current and past Biotage AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biotage AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Biotage AB's assets may result in an increase in income on the income statement.
The data published in Biotage AB's official financial statements usually reflect Biotage AB's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Biotage AB. For example, before you start analyzing numbers published by Biotage accountants, it's critical to develop an understanding of what Biotage AB's liquidity, profitability, and earnings quality are in the context of the Biotage space in which it operates.
Please note, the presentation of Biotage AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biotage AB's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Biotage AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotage AB. Please utilize our Beneish M Score to check the likelihood of Biotage AB's management manipulating its earnings.
Biotage AB Stock Summary
Biotage AB competes with Repligen, Intuitive Surgical, ResMed, Merit Medical, and ICU Medical. Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCGREY Exchange |
| Business Address | Box 8, Uppsala, |
| Benchmark | NYSE Composite |
| Website | www.biotage.com |
| Phone | 46 18 56 59 00 |
| Currency | USD - US Dollar |
You should never invest in Biotage AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Biotage OTC Stock, because this is throwing your money away. Analyzing the key information contained in Biotage AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Biotage AB Key Financial Ratios
Generally speaking, Biotage AB's financial ratios allow both analysts and investors to convert raw data from Biotage AB's financial statements into concise, actionable information that can be used to evaluate the performance of Biotage AB over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Biotage AB reports annually and quarterly.Biotage Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotage AB's current stock value. Our valuation model uses many indicators to compare Biotage AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotage AB competition to find correlations between indicators driving Biotage AB's intrinsic value. More Info.Biotage AB is rated second in return on equity category among related companies. It is rated second in return on asset category among related companies reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biotage AB is roughly 1.64 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biotage AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biotage AB's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotage AB's earnings, one of the primary drivers of an investment's value.Biotage AB Systematic Risk
Biotage AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biotage AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Biotage AB correlated with the market. If Beta is less than 0 Biotage AB generally moves in the opposite direction as compared to the market. If Biotage AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biotage AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biotage AB is generally in the same direction as the market. If Beta > 1 Biotage AB moves generally in the same direction as, but more than the movement of the benchmark.
About Biotage AB Financials
What exactly are Biotage AB Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Biotage AB's income statement, its balance sheet, and the statement of cash flows. Potential Biotage AB investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Biotage AB investors may use each financial statement separately, they are all related. The changes in Biotage AB's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotage AB's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Biotage AB Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Biotage AB is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Biotage has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Biotage AB's financials are consistent with your investment objective using the following steps:- Review Biotage AB's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Biotage AB's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Biotage AB's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Biotage AB's stock is overvalued or undervalued.
Biotage AB May 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biotage AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biotage AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biotage AB based on widely used predictive technical indicators. In general, we focus on analyzing Biotage OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biotage AB's daily price indicators and compare them against related drivers.
| Information Ratio | 0.0721 | |||
| Maximum Drawdown | 40.87 | |||
| Potential Upside | 12.24 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Biotage OTC Stock analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |